网站地图

/Ch/Index/aeReport

Forge Ahead with a New Chapter: Nuance Pharma Beijing Headquarters Grand Opening Ceremony Celebrated in Changping-MEDIA

Strategic Cooperation Agreement with SHAPHAR-Company News

Nuance Pharma advances Rare Disease R&D with CORD-Company News

优锐医药助力2022第十一届中国罕见病高峰论坛成功举办-Company News

优锐医药首席运营官陈晨对话蔻德 - 新浪《蕊智会》-Company News

优锐医药受邀出席中关村肾病血液净化创新联盟 “峥嵘五年再续华章” 五周年庆典-Company News

优锐医药恩塞芬汀中国III期临床试验全国研究者会顺利召开-Company News

优锐医药助力2023中国医疗健康峰会-Company News

Nuance Pharma Attended The 3rd BioCentury-BayHelix East-West Biopharma Summit in Singapore-Company News

Nuance Pharma Hosts National Investigators' Meeting in Shanghai for the STG320 (Actair®) Phase III Clinical Study (REACH Study)-Company News

Milestone in Beijing: Peking University Third Hospital issued the region's first prescription of Ensifentrine-Company News

STG320 (for House Dust Mite-induced Allergic Rhinitis)：Dosing of First Patient in REACH Phase III Trial-Company News

IRON DEFICIENCY ANEMIA